NESNX
Price
$64.87
Change
-$1.01 (-1.53%)
Updated
Nov 13 closing price
Net Assets
1.28B
VTSAX
Price
$160.60
Change
-$2.86 (-1.75%)
Updated
Nov 13 closing price
Net Assets
2.05T
Interact to see
Advertisement

NESNX vs VTSAX

Header iconNESNX vs VTSAX Comparison
Open Charts NESNX vs VTSAXBanner chart's image
Natixis US Equity Opportunities N
Price$64.87
Change-$1.01 (-1.53%)
VolumeN/A
Net Assets1.28B
Vanguard Total Stock Mkt Idx Adm
Price$160.60
Change-$2.86 (-1.75%)
VolumeN/A
Net Assets2.05T
NESNX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
NESNX vs. VTSAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NESNX is a Hold and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.05T vs. NESNX (1.28B). VTSAX pays higher dividends than NESNX: VTSAX (1.11) vs NESNX (0.25). NESNX was incepted earlier than VTSAX: NESNX (9 years) vs VTSAX (25 years). NESNX (0.82) is less costly to investors than VTSAX (0.04). NESNX is a more actively managed with annual turnover of: 33.00 vs. VTSAX (2.00). VTSAX has a lower initial minimum investment than NESNX: VTSAX (3000) vs NESNX (1000000). VTSAX annual gain was more profitable for investors over the last year : 11.52 vs. NESNX (4.29). VTSAX return over 5 years is better than : 80.80 vs. NESNX (33.42).
NESNXVTSAXNESNX / VTSAX
Total Expense Ratio0.760.041,900%
Annual Report Gross Expense Ratio0.820.042,050%
Fund Existence9 years25 years-
Gain YTD11.25013.95281%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B2.05T0%
Annual Yield % from dividends0.251.1122%
Returns for 1 year4.2911.5237%
Returns for 3 years50.4666.8975%
Returns for 5 years33.4280.8041%
Returns for 10 yearsN/A225.71-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVCT0.06N/A
+1.61%
Provectus Biopharmaceuticals, Inc.
CHTM1452.50N/A
N/A
Chatham Corp.
ORYZF3.61N/A
N/A
Oryzon Genomics SA
TCPFF0.35N/A
N/A
TRUE CORPORATION PUBLIC COMPANY LIMITED
AIXXF21.17-0.85
-3.84%
Aixtron SE